▶ 調査レポート

電気生理学的装置の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Electrophysiology Devices Market (Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。電気生理学的装置の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Electrophysiology Devices Market (Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2207A078資料のイメージです。• レポートコード:MRC2207A078
• 出版社/出版日:Transparency Market Research / 2022年5月
• レポート形態:英文、PDF、204ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、世界の電気生理学的装置市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(電気生理学的アブレーションカテーテル、電気生理学的診断用カテーテル、電気生理学的実験装置、アクセス装置、その他)分析、エンドユーザー別分析、疾患別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはMicroport Scientific Corporation、Biotronik SE & Co.KG、Koninklijke Philips N.V.、Medtronic plc、GE Healthcare、Boston Scientific Corporation、Biosense Webster, Inc.、Nihon Kohden Corporation、F. Siemens AG、Acutus Medicalなどが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の電気生理学的装置市場規模:製品別(電気生理学的アブレーションカテーテル、電気生理学的診断用カテーテル、電気生理学的実験装置、アクセス装置、その他)
・世界の電気生理学的装置市場規模:エンドユーザー別
・世界の電気生理学的装置市場規模:疾患別
・世界の電気生理学的装置市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Electrophysiology Devices Market – Scope of Report

TMR’s report on the global electrophysiology devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global electrophysiology devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global electrophysiology devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the electrophysiology devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global electrophysiology devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global electrophysiology devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global electrophysiology devices market.

The report delves into the competitive landscape of the global electrophysiology devices market. Key players operating in the global electrophysiology devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global electrophysiology devices market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market electrophysiology devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Electrophysiology Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Electrophysiology Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological advancements
5.2. Key Industry Events
5.3. COVID-19 Impact
6. Global Electrophysiology Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Electrophysiology Ablation Catheters
6.3.1.1. Cryoablation Electrophysiology Catheters
6.3.1.2. Radiofrequency Ablation Catheters
6.3.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
6.3.1.2.2. Conventional Radiofrequency Ablation Catheters
6.3.1.3. Laser Ablation Systems
6.3.1.4. Microwave Ablation Systems
6.3.1.5. Navigational Advanced Mapping Accessories
6.3.2. Electrophysiology Diagnostic Catheters
6.3.2.1. Conventional Electrophysiology Diagnostic Catheters
6.3.2.1.1. Steerable Diagnostic Catheters
6.3.2.1.2. Fixed Diagnostic Catheters
6.3.2.2. Advanced Electrophysiology Diagnostic Catheters
6.3.2.3. Ultrasound Electrophysiology Diagnostic Catheters
6.3.3. Electrophysiology Laboratory Devices
6.3.4. Access Devices
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Electrophysiology Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Clinics
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Electrophysiology Devices Market Analysis and Forecast, by Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Indication, 2017–2031
8.3.1. Atrial Fibrillation (AF)
8.3.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
8.3.3. Wolff-Parkinson-White Syndrome (WPW)
8.3.4. Atrial Flutter
8.3.5. Others
8.4. Market Attractiveness Analysis, by Indication
9. Global Electrophysiology Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Electrophysiology Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Electrophysiology Ablation Catheters
10.2.1.1. Cryoablation Electrophysiology Catheters
10.2.1.2. Radiofrequency Ablation Catheters
10.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
10.2.1.2.2. Conventional Radiofrequency Ablation Catheters
10.2.1.3. Laser Ablation Systems
10.2.1.4. Microwave Ablation Systems
10.2.1.5. Navigational Advanced Mapping Accessories
10.2.2. Electrophysiology Diagnostic Catheters
10.2.2.1. Conventional Electrophysiology Diagnostic Catheters
10.2.2.1.1. Steerable Diagnostic Catheters
10.2.2.1.2. Fixed Diagnostic Catheters
10.2.2.2. Advanced Electrophysiology Diagnostic Catheters
10.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
10.2.3. Electrophysiology Laboratory Devices
10.2.4. Access Devices
10.2.5. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Clinics
10.3.4. Others
10.4. Market Value Forecast, by Indication, 2017–2031
10.4.1. Atrial Fibrillation (AF)
10.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
10.4.3. Wolff-Parkinson-White Syndrome (WPW)
10.4.4. Atrial Flutter
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By End-user
10.6.3. By Indication
10.6.4. By Country
11. Europe Electrophysiology Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Electrophysiology Ablation Catheters
11.2.1.1. Cryoablation Electrophysiology Catheters
11.2.1.2. Radiofrequency Ablation Catheters
11.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
11.2.1.2.2. Conventional Radiofrequency Ablation Catheters
11.2.1.3. Laser Ablation Systems
11.2.1.4. Microwave Ablation Systems
11.2.1.5. Navigational Advanced Mapping Accessories
11.2.2. Electrophysiology Diagnostic Catheters
11.2.2.1. Conventional Electrophysiology Diagnostic Catheters
11.2.2.1.1. Steerable Diagnostic Catheters
11.2.2.1.2. Fixed Diagnostic Catheters
11.2.2.2. Advanced Electrophysiology Diagnostic Catheters
11.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
11.2.3. Electrophysiology Laboratory Devices
11.2.4. Access Devices
11.2.5. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Clinics
11.3.4. Others
11.4. Market Value Forecast, by Indication, 2017–2031
11.4.1. Atrial Fibrillation (AF)
11.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
11.4.3. Wolff-Parkinson-White Syndrome (WPW)
11.4.4. Atrial Flutter
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By End-user
11.6.3. By Indication
11.6.4. By Country/Sub-region
12. Asia Pacific Electrophysiology Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Electrophysiology Ablation Catheters
12.2.1.1. Cryoablation Electrophysiology Catheters
12.2.1.2. Radiofrequency Ablation Catheters
12.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
12.2.1.2.2. Conventional Radiofrequency Ablation Catheters
12.2.1.3. Laser Ablation Systems
12.2.1.4. Microwave Ablation Systems
12.2.1.5. Navigational Advanced Mapping Accessories
12.2.2. Electrophysiology Diagnostic Catheters
12.2.2.1. Conventional Electrophysiology Diagnostic Catheters
12.2.2.1.1. Steerable Diagnostic Catheters
12.2.2.1.2. Fixed Diagnostic Catheters
12.2.2.2. Advanced Electrophysiology Diagnostic Catheters
12.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
12.2.3. Electrophysiology Laboratory Devices
12.2.4. Access Devices
12.2.5. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Clinics
12.3.4. Others
12.4. Market Value Forecast, by Indication, 2017–2031
12.4.1. Atrial Fibrillation (AF)
12.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
12.4.3. Wolff-Parkinson-White Syndrome (WPW)
12.4.4. Atrial Flutter
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By End-user
12.6.3. By Indication
12.6.4. By Country/Sub-region
13. Latin America Electrophysiology Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Electrophysiology Ablation Catheters
13.2.1.1. Cryoablation Electrophysiology Catheters
13.2.1.2. Radiofrequency Ablation Catheters
13.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
13.2.1.2.2. Conventional Radiofrequency Ablation Catheters
13.2.1.3. Laser Ablation Systems
13.2.1.4. Microwave Ablation Systems
13.2.1.5. Navigational Advanced Mapping Accessories
13.2.2. Electrophysiology Diagnostic Catheters
13.2.2.1. Conventional Electrophysiology Diagnostic Catheters
13.2.2.1.1. Steerable Diagnostic Catheters
13.2.2.1.2. Fixed Diagnostic Catheters
13.2.2.2. Advanced Electrophysiology Diagnostic Catheters
13.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
13.2.3. Electrophysiology Laboratory Devices
13.2.4. Access Devices
13.2.5. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Clinics
13.3.4. Others
13.4. Market Value Forecast, by Indication, 2017–2031
13.4.1. Atrial Fibrillation (AF)
13.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
13.4.3. Wolff-Parkinson-White Syndrome (WPW)
13.4.4. Atrial Flutter
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By End-user
13.6.3. By Indication
13.6.4. By Country/Sub-region
14. Middle East & Africa Electrophysiology Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Electrophysiology Ablation Catheters
14.2.1.1. Cryoablation Electrophysiology Catheters
14.2.1.2. Radiofrequency Ablation Catheters
14.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
14.2.1.2.2. Conventional Radiofrequency Ablation Catheters
14.2.1.3. Laser Ablation Systems
14.2.1.4. Microwave Ablation Systems
14.2.1.5. Navigational Advanced Mapping Accessories
14.2.2. Electrophysiology Diagnostic Catheters
14.2.2.1. Conventional Electrophysiology Diagnostic Catheters
14.2.2.1.1. Steerable Diagnostic Catheters
14.2.2.1.2. Fixed Diagnostic Catheters
14.2.2.2. Advanced Electrophysiology Diagnostic Catheters
14.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
14.2.3. Electrophysiology Laboratory Devices
14.2.4. Access Devices
14.2.5. Others
14.3. Market Value Forecast, by End-user, 2017–2031
14.3.1. Hospitals
14.3.2. Diagnostic Centers
14.3.3. Clinics
14.3.4. Others
14.4. Market Value Forecast, by Indication, 2017–2031
14.4.1. Atrial Fibrillation (AF)
14.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
14.4.3. Wolff-Parkinson-White Syndrome (WPW)
14.4.4. Atrial Flutter
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By End-user
14.6.3. By Indication
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Acutus Medical, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. F. Siemens AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Nihon Kohden Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Biosense Webster, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Boston Scientific Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. GE Healthcare
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Medtronic plc
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Biotronik SE & Co.KG
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Microport Scientific Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. Other Player

List of Tables

Table 01: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Ablation Catheters, 2017–2031

Table 03: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by Radiofrequency Ablation Catheters, 2017–2031

Table 04: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Diagnostic Catheters, 2017–2031

Table 05: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by Conventional Electrophysiology Diagnostic Catheters, 2017–2031

Table 06: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 07: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: Global Electrophysiology Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 09: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Ablation Catheters, 2017–2031

Table 12: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Radiofrequency Ablation Catheters, 2017–2031

Table 13: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Diagnostic Catheters, 2017–2031

Table 14: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Conventional Electrophysiology Diagnostic Catheters, 2017–2031

Table 15: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 16: North America Electrophysiology Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 19: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Ablation Catheters, 2017–2031

Table 20: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by Radiofrequency Ablation Catheters, 2017–2031

Table 21: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Diagnostic Catheters, 2017–2031

Table 22: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by Conventional Electrophysiology Diagnostic Catheters, 2017–2031

Table 23: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 24: Europe Electrophysiology Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Asia Pacific electrophysiology devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Asia Pacific Electrophysiology Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Asia Pacific Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Ablation Catheters, 2017–2031

Table 28: Asia Pacific Electrophysiology Devices Market Value (US$ Mn) Forecast, by Radiofrequency Ablation Catheters, 2017–2031

Table 29: Asia Pacific Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Diagnostic Catheters, 2017–2031

Table 30: Asia Pacific Electrophysiology Devices Market Value (US$ Mn) Forecast, by Conventional Electrophysiology Diagnostic Catheters, 2017–2031

Table 31: Asia Pacific Electrophysiology Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 32: Asia Pacific Electrophysiology Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 33: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 34: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 35: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Ablation Catheters, 2017–2031

Table 36: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Radiofrequency Ablation Catheters, 2017–2031

Table 37: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Diagnostic Catheters, 2017–2031

Table 38: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Conventional Electrophysiology Diagnostic Catheters, 2017–2031

Table 39: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 40: Latin America Electrophysiology Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 41: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 42: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 43: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Ablation Catheters, 2017–2031

Table 44: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by Radiofrequency Ablation Catheters, 2017–2031

Table 45: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by Electrophysiology Diagnostic Catheters, 2017–2031

Table 46: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by Conventional Electrophysiology Diagnostic Catheters, 2017–2031

Table 47: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 48: Middle East & Africa Electrophysiology Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031